“Prescription of Glucagon-Like Peptide 1 (GLP-1) in the treatment of patients with type 2 diabetes and obesity: a literature review” (2022) Revista Eletrônica Acervo Médico, 11, p. e10289. doi:10.25248/reamed.e10289.2022.